Evidence map›Paper›PMID 40648676›Full record

ArticleNanomaterials (Basel, Switzerland)2025

SnS

Suresh Kumar Pandey, Sandra Romac, Josipa Papac Zjačić, Marijana Kraljić Roković, Marin Kovačić, Hrvoje Kušić, Boštjan Žener, Boštjan Genorio, Urška Lavrenčič Štangar, Ana Lončarić Božić

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Suresh Kumar PandeyFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.ORCID 0000-0003-3437-7116
Sandra RomacFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.
Josipa Papac ZjačićFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.
Marijana Kraljić RokovićFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.
Marin KovačićFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.
Hrvoje KušićFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.ORCID 0000-0001-9315-9202
Boštjan ŽenerFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.
Boštjan GenorioFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-0714-3472
Urška Lavrenčič ŠtangarFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.ORCID 0000-0001-9652-2257
Ana Lončarić BožićFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.ORCID 0000-0001-5853-5313

Funding

Croatian Science Foundation IPS-2022-02-4780
6 · The paper itself

Abstract

Contaminants of emerging concern (CECs), including pharmaceuticals and perfluorinated compounds, pose a growing threat to water quality due to their persistence and resistance to conventional treatment methods. In this context, photocatalytic processes capable of promoting both oxidative and reductive transformations have attracted increasing attention. This study explores the synthesis and performance of a SnS

Indexed as

contaminants of emerging concernreductive degradationSnS2-TiO2 compositesolar photocatalysis

Identifiers

PMID40648676
PMCPMC12251373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.